Pet Pharm Biotech Co., Ltd. (TPEX:7762)
55.60
+2.50 (4.71%)
At close: Oct 8, 2026
| Market Cap | 3.23B -22.9% |
| Revenue (ttm) | 265.54M +67.0% |
| Net Income | 30.03M +56.0% |
| EPS | 0.52 +24.9% |
| Shares Out | 58.09M |
| PE Ratio | 107.93 |
| Forward PE | n/a |
| Dividend | 0.25 (0.44%) |
| Ex-Dividend Date | Jul 20, 2026 |
| Volume | 142,656 |
| Open | 53.20 |
| Previous Close | 53.10 |
| Day's Range | 53.10 - 57.20 |
| 52-Week Range | 44.00 - 82.07 |
| Beta | 0.72 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |